Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 40Observational 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Keratosis, Actinic 5

Interventions

Blood Specimen Collection 22Surveys and Questionnaires 19Nivolumab 14Ipilimumab 12pembrolizumab 11Gene Expression Profiling 11Biopsy 10trametinib 9dabrafenib 8Flow Cytometry 8Specimen Handling 7Polymerase Chain Reaction 7Tomography, Optical Coherence 6Therapeutics 6Immunohistochemistry 6Imiquimod 6Amplified Fragment Length Polymorphism Analysis 6Watchful Waiting 5Psychiatric Rehabilitation 5Immunotherapy 5Data Collection 53-ingenyl angelate 5Mohs Surgery 4Microarray Analysis 4Interviews as Topic 4Immunoenzyme Techniques 4Drug Therapy 4Dermoscopy 4sonidegib 3encorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × 3-ingenyl angelate × Dermatologic × Clear all
NCT04202445 2023-06-09

MIKADO

LEO Pharma

Completed
1,218 enrolled
Dermatologic

Keratosis, Actinic

NCT02090465 2019-12-17

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

LEO Pharma

Completed
840 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT02421471 2019-12-13

PMS to Evaluate the Safety and Efficacy of Picato® Gel

LEO Pharma

Completed
1,324 enrolled
Dermatologic

Keratosis, Actinic

NCT02594436 2019-01-22

PrAKtice

LEO Pharma

Completed
440 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡